Showing 911 results

Filters Content type: News, Editors' picks, About HIV Topic: Starting treatment

Everyone who has diagnosed HIV is recommended to take HIV treatment. It is better for your health to begin HIV treatment sooner, rather than later.

HIV treatment for children & young people

NNRTI + 3 NRTIs may be strong first regimen in UK/Ireland children

Editor's pick
International AIDS Society
24 November 2014
Treatment outcomes & life expectancy

Restoring and maintaining a high CD4 count possible for vast majority of people living with HIV in France

News
12 November 2014
Undetectable viral load & treatment as prevention

What are the barriers that could stop HIV treatment becoming HIV prevention?

News
12 November 2014
New & experimental HIV treatments

Once-daily dolutegravir superior to darunavir/ritonavir in 96-week follow-up

News
10 November 2014
New & experimental HIV treatments

Doravirine works as well as efavirenz with fewer CNS side-effects

News
10 November 2014
Starting treatment

Early Initiation of Combo Antiretrovirals Gaining Support

Editor's pick
Medscape (requires registration)
7 November 2014
Treatment guidelines

Do emtricitabine and lamivudine have similar virological efficacy when used in first-line HIV therapy?

News
3 November 2014
Starting treatment

NNRTIs and protease inhibitors both good for first ART, channelling affects choices

News
22 October 2014
Side effects

Effective treatments available for HIV patients not eligible for efavirenz regimens

Editor's pick
Science Daily
7 October 2014
Starting treatment

Why I Refused, Then Later Embraced, HIV Treatment

Editor's pick
TheBody.com
1 October 2014
Adherence

Uganda: Aids Patients Reject Bitter ARVs

Editor's pick
Allafrica.com
10 September 2014
CD4 count

South African women living with HIV subtype C experience rapid CD4 cell loss

News
5 August 2014
Neurological & cognitive problems

Efavirenz use not linked to neurocognitive impairment

News
25 July 2014
Starting treatment

Men Who Have Sex With Men Getting Treatment Sooner

Editor's pick
MedPage Today
25 July 2014
HIV treatment

Dolutegravir demonstrates good efficacy despite resistance

News
24 July 2014
Epidemiology & behaviour

Could HIV treatment mean safer sex?

News
24 July 2014
Starting treatment

Maraviroc fails to match tenofovir/emtricitabine for first-line HIV treatment

News
23 July 2014
New & experimental HIV treatments

Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients

News
11 July 2014
Pregnancy and vertical transmission

Option B+: In obstacle courses to lifelong antiretroviral treatment, hurdles are higher for pregnant women, study says

Editor's pick
Science Speaks
9 July 2014
Treatment guidelines

New ARV prescribing guidelines for London (2014)

Editor's pick
HIV i-Base
1 July 2014
Treatment guidelines

Dolutegravir in HIV-1 infection: Added benefit in adult patients

Editor's pick
Science Daily
19 June 2014
New & experimental HIV treatments

First Patient Enrolled in New Phase 3 Trial Program Investigating a Once-Daily formulation of raltegravir (Isentress)

Editor's pick
Merck
6 June 2014
Starting treatment

Five-drug ART has no advantage over three drugs for early HIV

Editor's pick
International AIDS Society
4 June 2014
Nutrition

Ethiopia: HIV patient nutrition more vital than once assumed

Editor's pick
University of Copenhagen (press release)
15 May 2014